The SH2-containing tyrosine phosphatase corkscrew is required during signaling by sevenless, Ras1 and Raf

Development ◽  
1996 ◽  
Vol 122 (4) ◽  
pp. 1137-1146 ◽  
Author(s):  
J.D. Allard ◽  
H.C. Chang ◽  
R. Herbst ◽  
H. McNeill ◽  
M.A. Simon

The sevenless gene encodes a receptor tyrosine kinase which is required for the development of the R7 photoreceptor cell in each ommatidium of the Drosophila eye. We have previously used a sensitized genetic screen to identify mutations, designated Enhancers of sevenless (E(sev)), which affect genes that encode components of the sevenless signaling pathway. Here, we report that one of these mutations, E(sev)1Ae0P is a dominantly inhibiting allele of corkscrew, which encodes an SH2 domain-containing protein tyrosine phosphatase (Perkins et al., 1992). We show that corkscrew function is essential for sevenless signaling and that expression of a membrane-targeted form of corkscrew can drive R7 photoreceptor development in the absence of sevenless function. Furthermore, we have used the dominantly inhibiting corkscrew allele to examine the role of corkscrew during signaling by activated forms of Ras1 and Raf. Our analysis indicates that corkscrew function is still required during signaling by activated forms Ras1 and Raf proteins. These results define a function for corkscrew that is either downstream of Ras1 activation or in a parallel pathway that acts with activated Ras1/Raf to specify R7 photoreceptor development.

1996 ◽  
Vol 13 (3) ◽  
pp. 309-315 ◽  
Author(s):  
Robert F. Paulson ◽  
Shirly Vesely ◽  
Katharine A. Siminovitch ◽  
Alan Bernstein

1998 ◽  
Vol 18 (8) ◽  
pp. 4844-4854 ◽  
Author(s):  
Ngocdiep Le ◽  
Michael A. Simon

ABSTRACT DRK, the Drosophila homolog of the SH2-SH3 domain adaptor protein Grb2, is required during signaling by thesevenless receptor tyrosine kinase (SEV). One role of DRK is to provide a link between activated SEV and the Ras1 activator SOS. We have investigated the possibility that DRK performs other functions by identifying additional DRK-binding proteins. We show that the phosphotyrosine-binding (PTB) domain-containing protein Disabled (DAB) binds to the DRK SH3 domains. DAB is expressed in the ommatidial clusters, and loss of DAB function disrupts ommatidial development. Moreover, reduction of DAB function attenuates signaling by a constitutively activated SEV. Our biochemical analysis suggests that DAB binds SEV directly via its PTB domain, becomes tyrosine phosphorylated upon SEV activation, and then serves as an adaptor protein for SH2 domain-containing proteins. Taken together, these results indicate that DAB is a novel component of the SEV signaling pathway.


2002 ◽  
Vol 48 (3) ◽  
pp. 145-145
Author(s):  
Rico Pusch ◽  
Annette Böhmer ◽  
Christoph Biskup ◽  
Klaus Benndorf ◽  
Jörg Lindenau ◽  
...  

Molecules ◽  
2021 ◽  
Vol 26 (13) ◽  
pp. 3943
Author(s):  
Seyed Mohammad Gheibihayat ◽  
Ricardo Cabezas ◽  
Nikita G. Nikiforov ◽  
Tannaz Jamialahmadi ◽  
Thomas P. Johnston ◽  
...  

CD47 is a receptor belonging to the immunoglobulin (Ig) superfamily and broadly expressed on cell membranes. Through interactions with ligands such as SIRPα, TSP-1, integrins, and SH2-domain bearing protein tyrosine phosphatase substrate-1 (SHPS-1), CD47 regulates numerous functions like cell adhesion, proliferation, apoptosis, migration, homeostasis, and the immune system. In this aspect, previous research has shown that CD47 modulates phagocytosis via macrophages, the transmigration of neutrophils, and the activation of T-cells, dendritic cells, and B-cells. Moreover, several studies have reported the increased expression of the CD47 receptor in a variety of diseases, including acute lymphoblastic leukemia (ALL), chronic myeloid leukemia, non-Hodgkin’s lymphoma (NHL), multiple myeloma (MM), bladder cancer, acute myeloid leukemia (AML), Gaucher disease, Multiple Sclerosis and stroke among others. The ubiquitous expression of the CD47 cell receptor on most resident cells of the CNS has previously been established through different methodologies. However, there is little information concerning its precise functions in the development of different neurodegenerative pathologies in the CNS. Consequently, further research pertaining to the specific functions and roles of CD47 and SIRP is required prior to its exploitation as a druggable approach for the targeting of various neurodegenerative diseases that affect the human population. The present review attempts to summarize the role of both CD47 and SIRP and their therapeutic potential in neurodegenerative disorders.


Sign in / Sign up

Export Citation Format

Share Document